Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | CD44 | P16070 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7050050 | 0.91 | ESR1 (0.55) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL29580239 | 0.91 | ESR1 (0.55) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL27212622 | 0.91 | ESR1 (0.55) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL29503457 | 0.91 | MAPT (0.56) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL29579848 | 0.91 | MAPT (0.56) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL101126 | 0.91 | MAPT (0.56) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL20763932 | 0.91 | ESR1 (0.60) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL24242241 | 0.82 | ESR2 (0.51) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL25970902 | 0.82 | ESR1 (0.51) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL29412612 | 0.81 | ESR1 (0.65) | ESR1ESR2MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3720901-B1 | RESIN COMPOSITIONS FOR LIQUID RESIN INFUSION AND APPLICATIONS THEREOF | CYTEC IND INC (US) | 2022-02-09 | — | — | EP | disclosed |
| US-10011679-B2 | Modified amine curing agents, their preparation and use in curable compositions | CYTEC INDUSTRIES INC. (US) | 2018-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011679-B2 | Modified amine curing agents, their preparation and use in curable compositions | H1-4, H1-5, CECR2 | ESR1 2741/4885ESR2 2990/4885MEN1 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.